Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024

February 1, 2024

https://www.prnewswire.com/news-releases/curis-to-release-fourth-quarter-2023-financial-results-and-hold-conference-call-on-february-8-2024-302049568.html

LEXINGTON, Mass., Feb. 1, 2024 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company will release its fourth quarter 2023 financial results on Thursday, February 8, 2024, at 8:00 a.m. ET. Management will host a conference call at 8:30 a.m. ET.

Read more at prnewswire.com

Related news for (CRIS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.